InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Holtzman Douglas, Directeur Scientifique. Director active across 1 company, notably Icosavax, Inc.. In total, 8 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €224k. History available since 30 July 2021. The latest transaction was filed on 3 July 2023 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations8 total
16,356 shares@ US$1.041.2% of flowCommon StockSEC:0001209191-23-040716:0
20,443 shares@ US$1.041.5% of flowCommon StockSEC:0001209191-23-023467:0
1,522 shares@ US$10.69261.2% of flowCommon StockSEC:0001209191-23-009916:0
19,648 shares@ US$11.144315.7% of flowCommon StockSEC:0001209191-22-061736:0
585 shares@ US$7.10760.3% of flowCommon StockSEC:0001209191-22-044021:0
19,485 shares0Common StockSEC:0001209191-22-009513:0
41,500 shares@ US$15.0040.1% of flowCommon StockSEC:0000899243-21-031147
41,500 shares@ US$15.0050.0% of flowCommon StockSEC:0000899243-21-031147:0
8 of 8 declarations
About Holtzman Douglas
Douglas Holtzman is the Chief Scientific Officer of Icosavax, Inc. He is responsible for leading the company's research and development efforts, focusing on innovation in the biotechnology field. His role is crucial for the development of new therapies and for the strategic positioning of the company in the market.
